Eversept Partners, LP

Position in PCVX — Vaxcyte, Inc.

CIK 1697013 NEW YORK, NY

Position in PCVX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$36,619,109

-$17,085,746 QoQ

Shares Held

629,952

-31.8% QoQ

Ownership

0.423%

of shares outstanding

% of Portfolio

2.00%

of 13F equity value

Holder Rank

#40

of 325 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. PCVX ranks #7 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	913,880	$121,783,648
2	VERA	Vera Therapeutics, Inc.	2,212,770	$94,949,960
3	CLDX	Celldex Therapeutics, Inc.	1,785,941	$66,454,864
4	SNDX	Syndax Pharmaceuticals Inc	2,798,210	$61,168,870
5	IONS	Ionis Pharmaceuticals Inc	664,684	$52,702,794
6	TVTX	Travere Therapeutics, Inc.	798,973	$45,389,656
7	PCVX	Vaxcyte, Inc. This page	629,952	$36,619,109
8	GERN	Geron Corp	18,717,422	$23,958,300

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$36,619,109	629,952	-31.8%	Shares	Sole	2026-08-14
2026-03-31	$53,704,855	924,193	-22.8%	Shares	Sole	2026-05-15
2025-12-31	$55,262,893	1,197,722	-15.8%	Shares	Sole	2026-02-17
2025-09-30	$51,219,827	1,421,983	+9.5%	Shares	Sole	2025-11-14
2025-06-30	$42,214,690	1,298,514	+133.1%	Shares	Sole	2025-08-14
2025-03-31	$21,034,963	557,070	+336.6%	Shares	Sole	2025-05-15
2024-12-31	$10,444,353	127,588	+32.8%	Shares	Sole	2025-02-14
2024-06-30	$7,255,680	96,089	-51.3%	Shares	Sole	2024-08-14
2024-03-31	$13,479,680	197,331	-15.6%	Shares	Sole	2024-05-15
2023-12-31	$14,685,089	233,839	+22.8%	Shares	Sole	2024-02-14
2023-09-30	$9,708,121	190,430	-2.7%	Shares	Sole	2023-11-14
2023-06-30	$9,772,808	195,691	-34.6%	Shares	Sole	2023-11-08
2023-03-31	$11,208,394	299,050	+67.6%	Shares	Sole	2023-11-08
2022-12-31	$8,556,821	178,453	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.